Transgene SA
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TNG.PA | TVGN | GNLX | INO | BINV.ST | TRABI.BO | |
|---|---|---|---|---|---|---|
| Market cap | 213.14M | 95.87M | 88.68M | 167.50M | 247.42M | 190.94M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.5 | — | -2.6 | -3.9 | -1.0 | — |
| Price/book | 1.9 | -1.4 | 5.4 | 30.6 | 1.2 | 2.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −41.50% | −77.45% | −75.51% | −27.51% | −88.73% | −24.19% |
| Today | +1.06% | −3.38% | +2.08% | −2.41% | +4.88% | −1.95% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All TNG.PA news ›Buffer Rows Reduce Transgene Transmission from GM Sweet Orange Trees to 0.31 Percent in Pera Citrus
Researchers recently evaluated a buffer system designed to contain gene flow from genetically modified (GM) sweet orange trees to surrounding non-GM citrus plants. The study, conducted over 12 seasons across four field assays, utilized a…
Citrandarin buffer sharply reduces transgene flow in sweet orange trials
A Brazilian field study across 12 flowering seasons found that a citrandarin-centered border was associated with substantially lower transgene flow in sweet orange trials, although it did not prevent dispersal entirely.
Book on ‘Transgene Technology for Improvement of Cultivated Tomato’ was appreciated
HANAMKONDA, OCTOBER 16, 2026: The book titled “Transgene Technology for Improvement of Cultivated Tomato”, authored by G. Vikram, Dean, Faculty of Life Sciences, Vaagdevi Degree & P.G. College, and Rajinikanth, has r
Transgene jumps 20% on positive cancer vaccine data in early trial
Transgene shares surged 20% in early Paris trading on Thursday, after the French biotechnology company reported positive Phase 1 trial data on its vaccine candidate for head and neck cancer. ... Biotechnology & Medical Research Transgene…
Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026 information fournie par Boursorama CP 05/10/2026 à 08:00
Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026 Boursorama Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026 information fournie par Boursorama…
Transgene Biotek board to appoint Eswara Rao & Co as auditors
Transgene Biotek Limited has scheduled a Board of Directors meeting for Saturday, October 10, 2026, at 11:00 am. The primary agenda is to consider and approve the appointment of M/s. Eswara Rao & Co., Chartered Accountants, as the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- boursorama.com1
- marketscreener.com1
- scanx.trade1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.